204 related articles for article (PubMed ID: 21272935)
1. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
Yamada M; Ohata H; Momose K; Yamada M; Richelson E
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):37-47. PubMed ID: 8581347
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
5. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
Kisfalvi K; Guha S; Rozengurt E
J Cell Physiol; 2005 Mar; 202(3):880-90. PubMed ID: 15389644
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
10. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
Ryder NM; Guha S; Hines OJ; Reber HA; Rozengurt E
J Cell Physiol; 2001 Jan; 186(1):53-64. PubMed ID: 11147814
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
[TBL] [Abstract][Full Text] [Related]
15. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
17. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
18. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
[TBL] [Abstract][Full Text] [Related]
19. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.
Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ
Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988
[TBL] [Abstract][Full Text] [Related]
20. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
